Alcohol Withdrawal Seizures

Models of Seizures and Epilepsy

Volumn , Issue , 2006, Pages 161-177

  N'Gouemo, Prosper ^a   Rogawski, Michael A ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747770844     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088554-1/50015-3     Document Type: Chapter

References (168)

1. Atkin L. The Auditory Midbrain: Structure and Function in the Central Auditory Pathway 1986, Humana Press, Clifton.
2. Ballenger J.C., Post R.M. Kindling as a model for alcohol with-drawal syndromes. Br J Psychiatry 1978, 133:1-14.
3. Bayard M., McIntyre J., Hill K.R., Woodside J. Alcohol withdrawal syndrome. Am Fam Physician 2004, 69:1443-1450.
4. Becker H.C., Hale R.L. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures-an animal model of alcohol withdrawal kindling. Alcohol Clin Exp Res 1993, 17:94-98.
5. Becker H.C., Diaz-Granados J.L., Hale R.L. Exacerbation of ethanol withdrawal seizures in mice with a history of multiple withdrawal experience. Pharmacol Biochem Behav 1997, 57:179-183.
6. Becker H.C., Veatch L.M., Diaz-Granados J.L. Repeated ethanol withdrawal experience selectively alters sensitivity to different chemoconvulsant drugs in mice. Psychopharmacology (Berl) 1998, 139:145-153.
7. Belknap J.K., Metten P., Helms M.L., O'Toole L.A., Angeli-Gade S., Crabbe J.C., Phillips T.J. Quantitative trait loci (QTL) applications to substances of abuse: physical dependence studies with nitrous oxide and ethanol in BXD mice. Behav Genet 1993, 23:213-222.
8. Bonnet U., Banger M., Leweke F.M., Maschke M., Kowalski T., Gastpar M. Treatment of alcohol withdrawal syndrome with gabapentin. Pharmacopsychiatry 1999, 32:107-109.
9. Bozikas V., Petrikis P., Gamvrula K., Savvidou I., Karavatos A. Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:197-199.
10. Brailowsky S., Kunimoto M., Menini C., Silva-Barrat C., Riche, Naquet R. The GABA-withdrawal syndrome: a new model of focal epileptogenesis. Brain Res 1988, 442:175-179.
11. Brown D.J., Long W.C. Quality control in blood alcohol analysis: simultaneous quantitation and confirmation. J Anal Toxicol 1988, 12:279-283.
12. Buck K.J., Rademacher B.S., Metten P., Crabbe J.C. Mapping murine loci for physical dependence on ethanol. Psychopharmacology (Berl) 2002, 160:398-407.
13. Busto U., Sellers E.M., Naranjo C.A., Cappell H., Sanchez-Craig M., Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986, 315:854-859.
14. Cadete-Leite A., Tavares M.A., Pacheco M.M., Volk B., Paula-Barbosa M.M. Hippocampal mossy fiber-CA3 synapses after chronic alcohol consumption and withdrawal. Alcohol 1989, 6:303-310.
15. A receptors. Mol Pharmacol 2003, 63:53-64.
16. Cagetti E., Baicy K.J., Olsen R.W. Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats. Neuroreport 2004, 15:207-210.
17. Carpenter-Hyland E.P., Woodward J.J., Chandler L.J. Chronic ethanol induces synaptic but not extrasynaptic targeting of NMDA receptors. J Neurosci 2004, 24:7859-7868.
18. Carta M., Ariwodola O.J., Weiner J.L., Valenzuela C.F. Alcohol potently inhibits the kainate receptor-dependent excitatory drive of hippocampal interneurons. Proc Natl Acad Sci USA 2003, 100:6813-6818.
19. Carta M., Mameli M., Valenzuela C.F. Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. J Neurosci 2004, 24:3746-3751.
20. Carta M., Olivera D.S., Dettmer T.S., Valenzuela C.F. Ethanol withdrawal upregulates kainate receptors in cultured rat hippocampal neurons. Neurosci Lett 2002, 327:128-132.
21. Chakravarty D.N., Faingold C.L. Comparison of neuronal response patterns in the external and central nuclei of inferior colliculus during ethanol administration and ethanol withdrawal. Brain Res 1998, 783:102-108.
22. Chapman A.G., Croucher M.J., Meldrum B.S. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung 1984, 34:1261-1264.
23. Chapman A.G., Meldrum B.S. Non-competitive N-methyl- d-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur J Pharmacol 1989, 166:201-211.
24. Chu N.S. Carbamazepine: prevention of alcohol withdrawal seizures. Neurology 1979, 29:1397-1401.
25. Chu N.S. Prevention of alcohol withdrawal seizures with phenytoin in rats. Epilepsia 1981, 22:179-184.
26. Clemmesen L., Ingvar M., Hemmingsen R., Bolwig T.G. Local cerebral glucose consumption during ethanol withdrawal in the rat: effects of single and multiple episodes and previous convulsive seizures. Brain Res 1988, 453:204-214.
27. Costa E.T., Soto E.E., Cardoso R.A., Olivera D.S., Valenzuela C.F. Acute effects of ethanol on kainate receptors in cultured hippocampal neurons. Alcohol Clin Exp Res 2000, 24:220-225.
28. Crabbe J.C. Antagonism of ethanol withdrawal convulsions in withdrawal seizure prone mice by diazepam and abecarnil. Eur J Pharmacol 1992, 221:85-90.
29. Crabbe JC Alcohol and genetics: new models. Am J Med Genet 2002, 114:969-974.
30. Crabbe J., Kosobud A. Alcohol withdrawal seizures: genetic animal models. Alcohol and Seizures: Basic Mechanisms and Clinical Concepts 1990, 126-139. F.A. Davis, Philadelphia. R.J. Porter, R.H. Mattson (Eds.).
31. Crews F.T., Morrow A.L., Criswell H., Breese G. Effects of ethanol on ion channels. Int Rev Neurobiol 1996, 39:283-367.
32. Danober L., Deransart C., Depaulis A., Vergnes M., Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 1998, 55:27-57.
33. A receptors in mediating the effects of alcohol in the central nervous system. J Psychiatry Neurosci 2003, 28:263-274.
34. Deitrich R.A., Erwin V.G. Pharmacological Effects of Ethanol on the Nervous System 1996, CRC Press, Boca Raton.
35. Devaud L.L., Matthews D.B., Morrow AL. Gender impacts behavioral and neurochemical adaptations in ethanol-dependent rats. Pharmacol Biochem Behav 1999, 64:841-849.
36. A receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem 1997, 69:126-130.
37. Dodd P.R., Beckmann A.M., Davidson M.S., Wilce P.A. Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int 2000, 37:509-533.
38. D'Onofrio G., Rathlev N.K., Ulrich A.S., Fish S.S., Freedland E.S. Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med 1999, 340:915-919.
39. Duka T., Gentry J., Malcoholm R., Ripley T.L., Borlikova G., Stephens D.N., Veatch L.M., et al. Consequences of multiple withdrawals from alcohol. Alcohol Clin Exp Res 2004, 28:233-246.
40. Eckardt M.J., Campbell G.A., Marietta C.A., Majchrowicz E., Rawlings R.R., Weight F.F. Ethanol dependence and withdrawal selectively alter localized cerebral glucose utilization. Brain Res 1992, 584:244-250.
41. Ellis F.W., Pick J.R. Experimentally induced ethanol dependence in rhesus monkeys. J Pharmacol Exp Ther 1970, 175:88-93.
42. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology. Epilepsia 2001, 42:796-803.
43. Essardas-Daryanani H., Santolaria F.J., Gonzalex Reimers E., Jorge J.A., Batista Lopez N., Martin Hernandez F., Martinez Riera A., et al. Alcoholic withdrawal syndrome and seizures. Alcohol Alcohol 1994, 29:323-328.
44. Essig C.F., Jones B.E., Lam R.C. The effects of pentobarbital on alcohol withdrawal in dogs. Arch Neurol 1969, 20:554-558.
45. Evans M.S., Li Y., Faingold C.L. Inferior colliculus intracellular response abnormalities in vitro associated with susceptibility to ethanol withdrawal seizures. Alcoholism Clin Exp Res 2000, 24:1180-1186.
46. Faingold C.L. Neuronal networks in the genetically epilepsy-prone rat. Adv Neurol 1999, 79:311-321.
47. Faingold C.L. Emergent properties of CNS neuronal networks as targets for pharmacology: application to anticonvulsant drug action. Prog Neurobiol 2004, 72:55-85.
48. Faingold C.L., Riaz A. Ethanol withdrawal induces increased firing in inferior colliculus neurons associated with audiogenic seizure susceptibility. J Exp Neurol 1995, 132:91-98.
49. Faingold C.L., Riaz A. Increased responsiveness of pontine reticular formation neurons associated with audiogenic seizures susceptibility during ethanol. Brain Res 1994, 663:69-76.
50. Faingold C.L., Randall M.E. Pontine reticular formation neurons exhibit a premature and precipitous increase in acoustic responses prior to audiogenic seizures in genetically epilepsy-prone rats. Brain Res 1995, 704:218-226.
51. Faingold C.L., Li Y., Evans M.S. Decreased GABA and increased glutamate receptor-mediated activity on inferior colliculus neurons in vitro are associated with susceptibility to ethanol withdrawal seizures. Brain Res 2000, 868:287-295.
52. Faingold C.L., N'Gouemo P., Riaz A. Ethanol and neurotransmitter interaction. From molecular to integrative effects. Prog Neurobiol 1998, 55:509-535.
53. Fehr C., Shirley R.L., Metten P., Kosobud A.E., Belknap J.K., Crabbe J.C., Buck K.J. Potential pleiotropic effects of Mpdz on vulnerability to seizures. Genes Brain Behav 2004, 3:8-19.
54. Fehr C., Shirley R.L., Belknap J.K., Crabbe J.C., Buck K.J. Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene. J Neurosci. 2002, 22:3730-3738.
55. Feller D.J., Bassir J.M., Crabbe J.C., Le Fevre CA Audiogenic seizure susceptibility in WSP and WSR mice. Epilepsia 1994, 35:861-867.
56. Floyd D.W., Jung K.Y., McCool B.A. Chronic ethanol ingestion facilitates N-methyl- d-aspartate receptor function and expression in rat lateral/basolateral amygdala neurons. J Pharmacol Exp Ther 2003, 307:1020-1029.
57. Freedland E.S., McMicken D.B. Alcohol-related seizures, Part I: pathology, differential diagnostic, and evaluation. J Emerg Med 1993, 11:463-473.
58. Freedland E.S., McMicken D.B. Alcohol-related seizures, Part II: clinical presentation and management. J Emerg Med 1993, 11:605-618.
59. Freund G. Alcohol withdrawal syndrome in mice. Arch Neurol 1969, 21:315-320.
60. Frey G.D., McCown T.J., Breese G.R., Peterson S.L. GABAergic modulation of inferior colliculus excitability: role in ethanol withdrawal seizures. J Pharmacol Exp Ther 1986, 227:663-670.
61. Gessner P.K. Failure of diphenylhydantoin to prevent alcohol withdrawal convulsions in mice. Eur J Pharmacol 1974, 27:120-129.
62. Goldstein D.B. Sodium bromide and sodium valproate: effective suppressants of ethanol withdrawal reactions in mice. J Pharmacol Exp Ther 1979, 208:223-227.
63. Goldstein D.B., Pal N. Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 1971, 172:288-290.
64. Gonzalez L.P., Czachura J.F., Brewer K.W. Spontaneous versus elicited seizures following ethanol withdrawal: differential time course. Alcohol Alcohol 1989, 6:481-487.
65. Gonzalez L.P., Veatch L.M., Ticku M.K., Becker H.C. Alcohol withdrawal kindling: mechanisms and implications for treatment. Alcohol Clin Exp Res 2001, 25(5 suppl ISBRA):197S-201S.
66. Gora-Maslak G., McClearn G.E., Crabbe J.C., Phillips T.J., Belknap J.K., Plomin R. Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology. Psychopharmacology (Berl) 1991, 104:413-424.
67. Gorwood P., Limosin F., Batel P., Hamon M., Ades J., Boni C. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol Psychiatry 2003, 53:85-92.
68. Grant K.A., Snell L.D., Rogawski M.A., Thurkauf A., Tabakoff B. Comparison of the effects of the uncompetitive N-methyl- d-aspartate antagonist (±)-5-aminocarbonyl-10, 11-dihydro-5 H-dibenzo[a, d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J Pharmacol Exp Ther 1992, 260:1017-1022.
69. Green A.R., Davies E.M., Little H.J., Whittington M.A., Cross A.J. Action of chlormethiazole in a model of ethanol withdrawal. Psychopharmacology (Berl) 1990, 102:239-242.
70. Grunwald F., Schrock H., Biersack H.J., Kuschinsky W. Changes in local cerebral glucose utilization in the awake rat during acute and chronic administration of ethanol. J Nucl Med 1993, 34:798-803.
71. Guerrero-Figueroa R., Rye M.M., Gallant D.M., Bishop M.P. Electrographic and behavioral effects of diazepam during alcohol withdrawal stage in cats. Neuropharmacology 1970, 9:143-150.
72. Gulya K., Grant K.A., Valverius P., Hoffman P.L., Tabakoff B. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res 1991, 547:129-134.
73. Hanchar H.J., Wallner M., Olsen R.W. Alcohol effects on γ-aminobutyric acid type A receptors: are extrasynaptic receptors the answer?. Life Sci 2004, 76:1-8.
74. Hemmingsen R., Barry D.I., Hertz M.M., Klinken L. Cerebral flow and oxygen consumption during ethanol withdrawal in the rat. Brain Res 1979, 173:259-269.
75. Hillbom M., Pieninkeroinen I., Leone M. Seizures in alcohol-dependent patients. CNS Drugs 2003, 17:1013-1030.
76. Hoffman P.L., Tabakoff B. Alcohol dependence: a commentary on mechanisms. Alcohol Alcohol 1996, 31:333-340.
77. Hughes J.R., Fino J.J. A review of generators of the brainstem auditory evoked ptoentials: contribution of an experimental study. J Clin Neurophysiol 1985, 2:355-381.
78. Hunter B.E., Boast C.A., Walker D.W., Zornetzer S.F. Alcohol withdrawal syndrome in rats: neural and behavioral correlates. Pharmacol Biochem Behav 1973, 1:719-725.
79. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., Price M.T., et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000, 287:947-948.
80. Jobe P.C., Pichioni A.L., Chin L. Role of brain norepinephrine in audiogenic seizures in the rat. J Pharmacol Exp Ther 1973, 184:1-10.
81. A receptor-mediated inhibition in rat hippocampus after chronic intermittent ethanol treatment. Brain Res 1996, 709:221-228.
82. A receptors to allosteric modulatory drugs in rat hippocampus after chronic intermittent ethanol treatment. Alcohol Clin Exp Res 1998, 22:2165-2173.
83. Kliethermes C.L., Metten P., Belknap J.K., Buck K.J., Crabbe J.C. Selection for pentobarbiatal withdrawal severity: correlated differences in withdrawal from other sedative drugs. Brain Res 2004, 1009:17-25.
84. + channels. Nat Neurosci 1999, 2:1091-1097.
85. Kosten T.R., O'Connor P.G. Management of drug and alcohol withdrawal. N Engl J Med 2003, 348:1786-1795.
86. Krystal J.H., Petrakis I.L., Mason G., Trevisan L., D'Souza D.C. N-methyl-d-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 2003, 99:79-94.
87. Lieber C.S., DeCarli L.M. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin Exp Res 1982, 6:523-531.
88. Little H.J., Dolin S.J., Halsey M.J. Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci 1986, 39:2059-2065.
89. Lovinger D.M., White G. Ethanol potentiation of 5-hydroxytryptamine 3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol Pharmacol 1991, 40:263-270.
90. Lovinger D.M., White G., Weight F.F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 1989, 243:1721-1724.
91. Lovinger D.M., White G., Weight F.F. NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat. J Neurosci 1990, 10:1372-1379.
92. a receptor α4-subunit expression: possible relevance to alcohol dependence. J Neurochem 1997, 68:2485-2492.
93. Majchrowicz E. Induction of physical dependence on ethanol and associated metabolic and behavioral changes in rats. Psychopharmacologia 1975, 43:245-254.
94. Majumdar S.K. Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 1990, 27:201-207.
95. Maldve R.E., Chen X., Zhang T.A., Morrisett R.A. Ethanol selectively inhibits enhanced vesicular release at excitatory synapses: real-time visualization in intact hippocampal slices. Alcohol Clin Exp Res 2004, 28:143-152.
96. A receptor gene expression by ethanol in the rat hippocampus versus cerebral cortex. J Neurochem 1998, 70:1160-1166.
97. Mattson R.H. Seizures associated with alcohol use and alcohol withdrawal. Epilepsy-Diagnosis and Management 1983, 325-332. Little Brown, Boston. B. Feldman (Ed.).
98. Maxson S.C., Sze P.Y. Electroencephalographic correlates of audiogenic seizures during ethanol withdrawal in mice. Psychopharmacology 1976, 47:17-20.
99. Mayo-Smith M.F. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 1977, 278:144-151.
100. McCown T.J., Breese G.R. Multiple withdrawals from chronic ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. Alcohol Clin Exp Res 1990, 14:394-399.
101. Metten P., Belknap J.K., Crabbe J.C. Drug withdrawal convulsions and susceptibility to convulsions after short-term selective breeding for acute ethanol withdrawal. Behav Brain Res 1998, 95:113-122.
102. Metten P., Crabbe J.C. Common genetic determinants of severity of acute withdrawal from ethanol, pentobarbital and diazepam in inbred mice. Behav Pharmacol 1994, 5:533-547.
103. Metten P., Crabbe J.C. Genetic determinants of severity of acute withdrawal from diazepam in mice: commonality with ethanol and pentobarbital. Pharmacol Biochem Behav 1999, 63:473-479.
104. Mhatre M.C., McKenzie S.E., Gonzalez L.P. Diazepam during prior ethanol withdrawals does not alter seizure susceptibility during a subsequenct withdrawal. Pharmacol Biochem Behav 2001, 68:339-346.
105. A receptor alpha subunits reveal that chronic alcohol treatment downregulates alpha-subunit expression in rat brain regions. J Neurochem 1993, 61:1620-1625.
106. A and glycine receptors. Nature 1997, 389:385-389.
107. Morgan M.Y. The management of alcohol withdrawal using chlormethiazole. Alcohol Alcohol 1995, 30:771-774.
108. Morrisett R.A., Rezvani A.H., Overstreet D., Janowsky D.S., Wilson W.A., Swartzwelder H.S. MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur. J. Pharmacol. 1990, 176:103-105.
109. A receptor function and expression in brain. Alcohol 1990, 7:237-244.
110. Myrick H., Malcolm R., Brady K.T. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry 1998, 155:1632.
111. 2+ channel currents in inferior colliculus neurons. Neuropharmacology 2003, 45:429-437.
112. N'Gouemo P., Caspary D.M., Faingold C.L. Decreased GABA effectiveness in the inferior colliculus neurons during ethanol withdrawal in rats susceptibile to audiogenic seizures. Brain Res 1996, 724:200-204.
113. Neiman J., Noldy N.E., El-Nesr B., McDonough M., Carlen P.L. Late auditory evoked potentials in alcoholics: identifying those with a history of epileptic seizures during withdrawal. Ann NY Acad Sci 1991, 620:73-81.
114. Nevo I., Hamon M. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 1995, 26:305-342.
115. Newman L.M., Hoffman W.E., Miletich D.J., Albrecht R.F. Regional blood flow and cerebral metabolic changes during alcohol withdrawal and following midazolama therapy. Anesthesiology 1985, 63:395-400.
116. Newton P.M., Orr C.J., Wallace M.J., Kim C., Shin H.S., Messing R.O. Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. J Neurosci 2004, 24:9862-9869.
117. Ogren S.O. Chlormethiazole-mode of action. Acta Psychiatr. Scand Suppl 1986, 329:13-27.
118. Paula-Barbosa M.M., Brandao F., Madeira M.D., Cadete-Leite A. Structural changes in the hippocampal formation after long-term alcohol consumaption and withdrawal in the rat. Addiction 1993, 88:237-247.
119. Peininkeroinen I.P., Telakivi T.M., Hillbom M.E. Outcome in subject with alcohol-provoked seizures. Alcohol Clin Exp Res 1992, 16:955-959.
120. Peoples R.W., White G., Lovinger D.M., Weight F.F. Ethanol inhibition of N-methyl-D-aspartate-activated current in mouse hippocampal neurones: whole-cell patch-clamp analysis. Br J Pharmacol 1997, 122:1035-1042.
121. Perez-Velazquez J.L., Valiante T.A., Carlen P.L. Changes in calcium currents during ethanol withdrawal in a genetic mouse model. Brain Res 1994, 649:305-309.
122. Pieper W.A., Skeen M.J., McClure H.M., Bourne P.G. The chimpanzee as an animal model for investigating alcoholism. Science 1972, 176:71-73.
123. Pilke A., Partinen M., Kovanen J. Status epilepticus and alcohol abuse: an analysis of 82 status epilepticus admissions. Acta Neurol Scand 1984, 70:443-450.
124. Pilip S., Urbanska E.M., Czuczwar S.J., Kleinrok Z., Turski W.A. Chlormethiazole anticonvulsive efficacy diminished by N-methyl-d-aspartate but not kainate in mice. Eur J Pharmacol 1998, 345:257-260.
125. Pinel J.P. Alcohol withdrawal seizures: implications of kindling. Pharmacol Biochem Behav 1980, 13(suppl 1):225-231.
126. Prendergast M.A., Harris B.R., Mullholland P.J., Blanchard J.A., Gibson D.A., Holley R.C., Littleton J.M. Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-d-aspartate receptors. Neuroscience 2004, 124:869-877.
127. Rathlev N.K., D'Onofrio G., Fish S.S., Harrison P.M., Bernstein E., Hossack R.W., Pickens L. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med 1994, 23:513-518.
128. Riaz A., Faingold C.L. Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation. Alcohol Clin Exp Res 1994, 18:1456-1462.
129. Ripley J.B. A 39-year-old man with fatal alcohol withdrawal seizures. J Emerg Nurs 1990, 16:67-79.
130. Ripley T.L., Dunworth S.J., Stephens D.N. Effects of CGP39551 administration on the kindling of ethanol-withdrawal seizures. Psychopharmacology 2002, 163:157-165.
131. Roberts A.J., Crabbe J.C., Keith L.D. Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res 1992, 579:296-302.
132. Rogawski M.A., Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
133. Rogawski M.A., Yamaguchi S., Jones S.M., Rice K.C., Thurkauf A., Monn J.A. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,da,d]cyclohepten-5 ,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine. J Pharmacol Exp Ther 1991, 259:30-37.
134. Rossetti Z.L., Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 1995, 283:177-183.
135. Rustembegovic A., Sofic E., Tahirovic I., Kundurovic Z. A study of gabapentin in the treatment of tonic-clonic seizures of alcohol withdrawal syndrome. Med Arh 2004, 58:5-6.
136. Ruwe W.D., Bauce L., Flemons W.W., Veale W.L., Pittman Q.J. Alcohol dependence and withdrawal in the rat: an effective means of induction and assessment. J Pharmacol Meth 1986, 15:225-234.
137. Sand T., Brathen G., Michler R., Brodtkorb E., Helde G., Bovim G. Clinical utility of EEG in alcohol-related seizures. Acta Neurol Scand 2002, 105:18-24.
138. Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., Rommelspacher H., et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 1997, 41:299-304.
139. A receptor gene expression associated with selective alteration in receptor function and pharmacology after ethanol withdrawal. J Neurosci 2003, 23:11711-11724.
140. Schaumann B.A., Annegers J.F., Johnson S.B., Moore K.J., Lubozynski M.F., Salinsky M.C. Family history of seizures in posttraumatic and alcohol-associated seizure disorders. Epilepsia 1994, 35:48-52.
141. Schmidt L.G., Sander T. Genetics of alcohol withdrawal. Eur Psychiatry 2000, 15:135-139.
142. Scorza F.A., Arida R.M., Cysneiros R.M., Priel M.R., de Albuquerque M., Cavalheiro E.A. The effects of alcohol intake and withdrawal on the seizures frequency and hippocampal morpphology in rats with epilepsy. Neurosci Res 2003, 47:323-328.
143. Snead O.C. Basic mechanisms of generalized absence seizures. Ann Neurol 1995, 37:146-157.
144. Snell L.D., Nunley K.R., Lickteig R.L., Browning M.D., Tabakoff B., Hoffman P.L. Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion. Mol Brain Res 1996, 40:71-78.
145. Stuppaeck C.H., Deisenhammer E.A., Kurz M., Whitworth A.B., Hinterhuber H. The irreversible γ-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome. Alcohol Alcohol 1996, 31:109-111.
146. Swinyard E.A., Castellion A.W. Anticonvulsant properties of some benzodiazepines. J Pharmacol Exp Ther 1966, 151:369-375.
147. Touchon J., Besset A., Baldy-Moulinier M., Billiard M., Uziel A., Passouant P. Electrophysiological aspect of alcoholic epilepsy. Rev Electroencephalogr Neurophysiol 1981, 14:133-137.
148. Touchon J., Rondouin G., DeLustrac C., Billiard M., Baldy-Moulinier M., Cadilhac M. Brainstem auditory evoked potential in "alcoholic epilepsy. Rev Electroencephalogr Neurophysiol 1984, 14:133-137.
149. Trevisan L., Fitzgerald L.W., Brose N., Gasic G.P., Heinemann S.F., Duman R.S., Nestler E.J. Chronic ingestion of ethanol upregulates NMDAR1 receptor subunit immunoreactivity in hippocampus. J Neurochem 1994, 62:1635-1638.
150. Uhl G.R. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism. Mov Disord 2003, 18(suppl 7):S71-S80.
151. Ulrichsen J., Bech B., Allerup P., Hemmingsen R. Diazepam prevents progression of kindled alcohol withdrawal behaviour. Psychopharmacology (Berl) 1995, 121:451-460.
152. A and NMDA receptors. Br J Pharmacol 2003, 140:1045-1050.
153. Vandenbergh D.J., Persico A.M., Uhl G.R. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res 1992, 15:161-166.
154. Veatch L.M., Becker H.C. Electrographic and behavioral indices of ethanol withdrawal sensitization. Brain Res 2002, 946:272-282.
155. Victor M., Brausch C. The role of abstinence in the genesis of alcoholic epilepsy. Epilepsy 1967, 8:1-20.
156. Voris J., Smith N.L., Rao S.M., Thorne D.L., Flowers Q.J. Gabapentin for the treatment of ethanol withdrawal. Subst Abus 2003, 24:129-132.
157. Walker D.W., Barnes D.E., Hunter B.E., Zornetzer J.F., Kubanis P. Neuronal loss in hippocampus induced by prolonged ethanol consumption in rats. Science 1980, 209:773-778.
158. Walter H., Messing R.O. Regulation of neuronal voltage-gated calcium channels by ethanol. Neurochem Int 1999, 35:95-101.
159. Watson W.P., Robinson E., Little H.J. The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome. Neuropharmacology 1997, 36:1369-1375.
160. A receptors in hippocampal neurons. J Neurosci 2004, 24:8379-8382.
161. White H.S., Woodhead J.H., Wilcox K.S., Stables J.P., Kupferberg H.J., Wolf H.H. General principles: discovery and preclinical development of antiepileptic drugs. Antiepileptic Drugs 2002, Lippincott Williams & Wilkins, Philadelphia. 5th ed. R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca (Eds.).
162. Whittington M.A., Lambert J.D., Little H.J. Increases in synaptic activation of calcium current as a mechanism for generation of ethanol withdrawal seizures. Alcohol Alcohol 1993, 2:391-394.
163. Whittington M.A., Lambert J.D., Little H.J. Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol 1995, 30:105-114.
164. Wirkner K., Poelchen W., Koles L., Muhlberg K., Scheibler P., Allgaier C., Illes P. Ethanol-induced inhibition of NMDA receptor channels. Neurochem Int 1999, 35:153-162.
165. Yang L., Long C., Faingold C.L. Neurons in the deep layers of supperior colliculus are a requisite component of the neuronal network for seizures during ethanol withdrawal. Brain Res 2001, 920:134-141.
166. Yang L., Long C., Faingold C.L. Audiogenic seizure susceptibility is induced by termination of continuous infusion of γ-aminobutyric acid or an N-methyl-D-aspartic acid antagonist into the inferior colliculus. Exp Neurol 2001, 171:147-152.
167. Yang L., Long C., Faingold C.L. Neurons in the periaqueductal gray are critically involved in the neuronal network for audiogenic seizures during ethanol withdrawal. Neuropharmacology 2003, 44:275-281.
168. Yang L., Long C., Evans M.S., Faingold C.L. Ethanol withdrawal results in aberrant membrane properties and synaptic responses in periaqueductal gray neurons associated seizure susceptibility. Brain Res 2002, 957:99-108.